{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,11,4]],"date-time":"2026-11-04T17:40:10Z","timestamp":1793814010820,"version":"4.6.1"},"reference-count":25,"publisher":"European Respiratory Society (ERS)","issue":"4","license":[{"start":{"date-parts":[[2023,5,18]],"date-time":"2023-05-18T00:00:00Z","timestamp":1684368000000},"content-version":"vor","delay-in-days":0,"URL":"http:\/\/creativecommons.org\/licenses\/by\/4.0\/"}],"funder":[{"DOI":"10.13039\/100020483","name":"Insmed","doi-asserted-by":"publisher","id":[{"id":"10.13039\/100020483","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["publications.ersnet.org"],"crossmark-restriction":true},"short-container-title":["ERJ Open Res"],"accepted":{"date-parts":[[2023,4,23]]},"published-print":{"date-parts":[[2023,7]]},"abstract":"<jats:sec><jats:title>Background<\/jats:title><jats:p>Patients with bronchiectasis experience persistent symptoms and frequent pulmonary exacerbations; this study investigated the frequency of exacerbations and all-cause hospitalisation.<\/jats:p><\/jats:sec><jats:sec><jats:title>Methods<\/jats:title><jats:p>This longitudinal, retrospective, claims database study (IBM\u00ae MarketScan\u00ae) identified patients aged \u226518\u2005years from 1 July 2015 through 30 September 2018. Exacerbations were identified by bronchiectasis inpatient claim or a healthcare interaction, followed by antibiotic prescription within 7\u2005days. Patients with \u226536\u2005months of continuous health plan enrolment (12\u2005months preceding the first bronchiectasis claim,<jats:italic>i.e.<\/jats:italic>, baseline period and \u226524\u2005months of follow-up) were included. Patients with cystic fibrosis at baseline were excluded. A multivariable logistic regression model identified baseline factors associated with having \u22652 exacerbations over the 2-year follow-up period.<\/jats:p><\/jats:sec><jats:sec><jats:title>Results<\/jats:title><jats:p>In total, 14\u2009798 patients with bronchiectasis were identified; 64.5% were female, 82.7% were aged \u226555\u2005years and 42.7% had \u22652 exacerbations at baseline. Having \u22652 exacerbations after 2\u2005years was positively associated with chronic macrolide use, long-acting \u03b22 agonist use, gastro-oesophageal reflux disease, heart failure and<jats:italic>Pseudomonas aeruginosa<\/jats:italic>. Frequent exacerbations (\u22652) at baseline were significantly associated with greater likelihood of experiencing \u22652 exacerbations during the first and second year's follow-up (unadjusted odds ratios 3.35 (95% CI 3.1\u20133.6) and 2.96 (95% CI 2.8\u20133.2), respectively). The proportion of patients experiencing \u22651 all-cause hospitalisation cumulatively increased from 41.0% in the first year of follow-up to 51.1% over 2\u2005years' follow-up.<\/jats:p><\/jats:sec><jats:sec><jats:title>Conclusion<\/jats:title><jats:p>Frequent exacerbations in patients with bronchiectasis may increase the likelihood of future exacerbations over 2\u2005years of follow-up, with increased hospitalisation rates over time.<\/jats:p><\/jats:sec>","DOI":"10.1183\/23120541.00021-2023","type":"journal-article","created":{"date-parts":[[2023,5,18]],"date-time":"2023-05-18T16:20:42Z","timestamp":1684426842000},"page":"00021-2023","update-policy":"https:\/\/doi.org\/10.1183\/ers-crossmark-policy","source":"Crossref","is-referenced-by-count":12,"title":["Pulmonary exacerbations in insured patients with bronchiectasis over 2\u2005years"],"prefix":"10.1183","volume":"9","author":[{"given":"Patrick A.","family":"Flume","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Joseph","family":"Feliciano","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Matthew","family":"Lucci","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jasmanda","family":"Wu","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Sebastian","family":"Fucile","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Mariam","family":"Hassan","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Anjan","family":"Chatterjee","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"81","published-online":{"date-parts":[[2023,5,18]]},"reference":[{"key":"2024101711584876000_9.4.00021-2023.1","doi-asserted-by":"publisher","DOI":"10.1183\/16000617.0055-2019"},{"key":"2024101711584876000_9.4.00021-2023.2","doi-asserted-by":"crossref","first-page":"880","DOI":"10.1016\/S0140-6736(18)31767-7","article-title":"Advances in bronchiectasis: endotyping, genetics, microbiome, and disease heterogeneity","volume":"392","author":"Flume","year":"2018","journal-title":"Lancet"},{"key":"2024101711584876000_9.4.00021-2023.3","doi-asserted-by":"publisher","DOI":"10.1183\/13993003.00629-2017"},{"key":"2024101711584876000_9.4.00021-2023.4","doi-asserted-by":"publisher","DOI":"10.1183\/13993003.01033-2015"},{"key":"2024101711584876000_9.4.00021-2023.5","doi-asserted-by":"crossref","first-page":"377","DOI":"10.1177\/1479972317709649","article-title":"Prevalence and incidence of noncystic fibrosis bronchiectasis among US adults in 2013","volume":"14","author":"Weycker","year":"2017","journal-title":"Chron Respir Dis"},{"key":"2024101711584876000_9.4.00021-2023.6","doi-asserted-by":"crossref","first-page":"21","DOI":"10.1016\/j.rmed.2019.09.012","article-title":"Epidemiology of bronchiectasis in the UK: findings from the British Lung Foundation's \u2018Respiratory Health of the Nation' project","volume":"158","author":"Snell","year":"2019","journal-title":"Respir Med"},{"key":"2024101711584876000_9.4.00021-2023.7","doi-asserted-by":"publisher","DOI":"10.1378\/chest.09-2932"},{"key":"2024101711584876000_9.4.00021-2023.8","doi-asserted-by":"publisher","DOI":"10.1164\/rccm.201309-1575OC"},{"key":"2024101711584876000_9.4.00021-2023.9","doi-asserted-by":"publisher","DOI":"10.1007\/s40258-013-0027-z"},{"key":"2024101711584876000_9.4.00021-2023.10","doi-asserted-by":"crossref","first-page":"A116","DOI":"10.1016\/j.jval.2016.03.458","article-title":"Resource uilization associated with non-cystic fibrosis bronchiectasis patients who are being treated for exacerbations","volume":"19","author":"Germino","year":"2016","journal-title":"Val Health"},{"key":"2024101711584876000_9.4.00021-2023.11","doi-asserted-by":"crossref","first-page":"54","DOI":"10.1186\/s12890-019-0818-6","article-title":"The economic burden of bronchiectasis \u2013 known and unknown: a systematic review","volume":"19","author":"Goeminne","year":"2019","journal-title":"BMC Pulm Med"},{"key":"2024101711584876000_9.4.00021-2023.12","doi-asserted-by":"crossref","first-page":"1410","DOI":"10.1164\/rccm.201711-2202OC","article-title":"Characterization of the \u2018frequent exacerbator phenotype\u2019 in bronchiectasis","volume":"197","author":"Chalmers","year":"2018","journal-title":"Am J Respir Crit Care Med"},{"key":"2024101711584876000_9.4.00021-2023.13","unstructured":"Hansen L. IBM MarketScan Research Databases for Life Sciences Researchers. Ann Arbor, MI, IBM Watson Health, 2018."},{"key":"2024101711584876000_9.4.00021-2023.14","doi-asserted-by":"crossref","first-page":"427","DOI":"10.2147\/COPD.S346591","article-title":"Frequency and severity of exacerbations of COPD associated with future risk of exacerbations and mortality: a UK routine health care data study","volume":"17","author":"Whittaker","year":"2022","journal-title":"Int J Chron Obstruct Pulmon Dis"},{"key":"2024101711584876000_9.4.00021-2023.15","doi-asserted-by":"crossref","first-page":"593","DOI":"10.2147\/COPD.S350248","article-title":"Relationship of COPD exacerbation severity and frequency on risks for future events and economic burden in the Medicare fee-for-service population","volume":"17","author":"Sethi","year":"2022","journal-title":"Int J Chron Obstruct Pulmon Dis"},{"key":"2024101711584876000_9.4.00021-2023.16","doi-asserted-by":"publisher","DOI":"10.4103\/0974-777X.150885"},{"key":"2024101711584876000_9.4.00021-2023.17","doi-asserted-by":"publisher","DOI":"10.1186\/1471-2466-13-34"},{"key":"2024101711584876000_9.4.00021-2023.18","doi-asserted-by":"crossref","first-page":"209","DOI":"10.4046\/trd.2014.77.5.209","article-title":"The effects of bronchiectasis on asthma exacerbation","volume":"77","author":"Kang","year":"2014","journal-title":"Tuberc Respir Dis (Seoul)"},{"key":"2024101711584876000_9.4.00021-2023.19","doi-asserted-by":"publisher","DOI":"10.1183\/13993003.01862-2015"},{"key":"2024101711584876000_9.4.00021-2023.20","doi-asserted-by":"crossref","first-page":"176","DOI":"10.1186\/s12931-017-0659-x","article-title":"Factors associated with hospitalization in bronchiectasis exacerbations: a one-year follow-up study","volume":"18","author":"Men\u00e9ndez","year":"2017","journal-title":"Respir Res"},{"key":"2024101711584876000_9.4.00021-2023.21","first-page":"7","article-title":"Exacerbations in COPD patients with bronchiectasis","volume":"5","author":"Minov","year":"2017","journal-title":"Med Sci (Basel)"},{"key":"2024101711584876000_9.4.00021-2023.22","doi-asserted-by":"publisher","DOI":"10.1378\/chest.11-2209"},{"key":"2024101711584876000_9.4.00021-2023.23","doi-asserted-by":"publisher","DOI":"10.1016\/j.chest.2018.07.014"},{"key":"2024101711584876000_9.4.00021-2023.24","doi-asserted-by":"publisher","DOI":"10.1183\/23120541.00786-2020"},{"key":"2024101711584876000_9.4.00021-2023.25","doi-asserted-by":"crossref","first-page":"423","DOI":"10.2147\/CEOR.S162021","article-title":"The burden of cystic fibrosis in the Medicaid population","volume":"10","author":"Hassan","year":"2018","journal-title":"Clinicoecon Outcomes Res"}],"container-title":["ERJ Open Research"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/syndication.highwire.org\/content\/doi\/10.1183\/23120541.00021-2023","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2025,2,24]],"date-time":"2025-02-24T05:26:50Z","timestamp":1740374810000},"score":1,"resource":{"primary":{"URL":"https:\/\/publications.ersnet.org\/lookup\/doi\/10.1183\/23120541.00021-2023"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2023,5,18]]},"references-count":25,"journal-issue":{"issue":"4","published-online":{"date-parts":[[2023,7,3]]},"published-print":{"date-parts":[[2023,7]]}},"alternative-id":["10.1183\/23120541.00021-2023"],"URL":"https:\/\/doi.org\/10.1183\/23120541.00021-2023","relation":{},"ISSN":["2312-0541"],"issn-type":[{"value":"2312-0541","type":"electronic"}],"subject":[],"published":{"date-parts":[[2023,5,18]]}}}